U.S. Remote Patient Monitoring Size, Share, Trends & Growth Forecast Report – Segmented By Type (Breath Monitors, Physical Activity Monitors, Heart Monitors, Hematological Monitors and Multi-Sign Monitors), Application and End-User, Industry Analysis from 2024 to 2032

Updated On: June, 2024
ID: 10095
Pages: 100

U.S. Remote Patient Monitoring Market Size

The remote patient monitoring market size in the U.S was valued at USD 2523 Million in 2023. The U.S. market is estimated to grow at a CAGR of 16.14% from 2024 to 2032 and be worth USD 9699 million by 2032 from USD 2930 million in 2024.

MARKET DRIVERS

The growing aging population in the U.S. and lifestyle changes are majorly driving the remote patient monitoring market in the U.S. The geriatric population is more prone to chronic illnesses like cardiovascular, diabetes, cancer, and others. According to a recent US Bureau data survey, the number of people aged above 65 is to reach more than 98 million, which is double the number of people in 2016 (46 million). It is significantly affecting the people who use these devices to have complete healthcare at home. It is predicted that there will be a lack of professionals in the coming years, and these new technologies will prompt healthcare services globally. Increasing healthcare costs and developing the latest techniques by researchers are propelling the growth rate of the market. The benefits conquered with the RPM devices, like fewer visits to hospitals and reduced time to stay in hospitals, enhance the market's growth rate. Remote patient monitoring devices are very useful in monitoring patients from different locations. These are gaining traction in giving excellent care for older people staying at home with chronic illnesses. These devices also provide the caregivers with proper assistance through the alert systems that are equipped in the device. 

By 2030, the diabetes patient population may grow to 29.6% in the US. The number of heart-related disorders will triple in the coming years, according to the latest studies. Diabetes is the number one concern for all people worldwide, as the number of patients is surging every year. It is estimated that diabetes patients toll up to 25 million by 2030, particularly in the US. In 2011, the number of deaths due to diabetes was 4.6 million in this country. 

Many private organizations have started using RPM techniques and are gaining traction through this. Traveling long distances is a big issue for geriatric people, who find it difficult to visit hospitals and clinics. RPM has sorted out this problem so far as it connects the healthcare professional and patient remotely. The attribute, as mentioned above, positively impacts the market growth in the U.S. 

MARKET RESTRAINTS

However, the lack of complete knowledge in operating the devices, especially in rural areas, is a big challenge that market players face. Failure of the systems in real-time applications also impedes the U.S. market growth. Risk factors included in RPM's use, such as the insertion of various devices like cardiac arrhythmias, air embolism, and others, are factors degrading the market's growth rate. 

COUNTRY ANALYSIS

In the North American region, the U.S. is thriving to hit the largest share of the market. Growing incidences of chronic diseases like diabetes are leveling up the growth rate of the market. Besides, creating awareness through campaigns in rural areas and raising funds by government organizations accelerates market demand. People in urban areas are spending a large amount on healthcare, prompting the remote patient monitoring market in the United States.

KEY MARKET PLAYERS

Companies playing a promising role in the U.S. remote patient monitoring market profiled in this report are Welch Allyn, Bosch, Johnson & Johnson, Intel, Roche, Philips Healthcare, Philips, Healthanywhere Inc, Honeywell, American Telecare, Biotronik, and Covidien Plc.

MARKET SEGMENTATION

This research report on the U.S. remote patient monitoring market is segmented and sub-segmented into the following categories.

By Type

  • Breath Monitors
  • Physical Activity Monitors
  • Heart Monitors
  • Hematological Monitors
  • Multi-Sign Monitors

By Application

  • Cancer Treatment
  • Cardiovascular Diseases
  • Diabetes Treatment
  • Sleep Disorder and Weight Management
  • Fitness Monitoring

By End-Use

  • Ambulatory Care Centres
  • Hospitals
  • Home Healthcare

By Country

  • The United States

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample